The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.
Anna KiepuraMaciej SuskiKamila StachyraKatarzyna KuśKlaudia CzepielAnna WiśniewskaMagdalena Ulatowska-BiałasRafal OlszaneckiPublished in: Cardiovascular drugs and therapy (2023)
Pharmacological stimulation of FFAR4 may represent a promising lead in the search for drugs that inhibit NAFLD.